S-1 chemotherapy and intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with node-positive gastric cancer: a phase I/II study

BACKGROUND: This phase I/II clinical trial investigated S-1 administered with intensity-modulated radiotherapy (IMRT) as adjuvant therapy for node-positive gastric cancer. Patients had undergone radical resection and D1/D2 lymph node dissection. METHODS: In phase I, patients received adjuvant chemor...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, X, Zhao, D B, Yang, L, Chi, Y, Tang, Y, Li, N, Wang, S L, Song, Y W, Liu, Y P, Liu, W Y, Ren, H, Zhang, T, Wang, J Y, Chen, X S, Fang, H, Wang, W H, Li, Y X, Jin, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808036/
https://www.ncbi.nlm.nih.gov/pubmed/29235569
http://dx.doi.org/10.1038/bjc.2017.424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808036/
https://www.ncbi.nlm.nih.gov/pubmed/29235569
http://dx.doi.org/10.1038/bjc.2017.424

Ejemplares similares